|
|
 |
|
Total Number of Holdings (excluding cash): 50
| Exact Sciences Corporation |
EXAS |
30063P105 |
684 |
$69,282.36 |
3.24% |
| Globus Medical, Inc. (Class A) |
GMED |
379577208 |
705 |
$64,183.20 |
3.00% |
| Intuitive Surgical, Inc. |
ISRG |
46120E602 |
93 |
$53,333.64 |
2.49% |
| Waters Corporation |
WAT |
941848103 |
120 |
$48,410.40 |
2.26% |
| Revvity, Inc. |
RVTY |
714046109 |
452 |
$47,193.32 |
2.21% |
| Align Technology, Inc. |
ALGN |
016255101 |
317 |
$46,659.23 |
2.18% |
| Edwards Lifesciences Corporation |
EW |
28176E108 |
539 |
$46,715.13 |
2.18% |
| Mettler-Toledo International Inc. |
MTD |
592688105 |
31 |
$45,778.32 |
2.14% |
| The Cooper Companies, Inc. |
COO |
216648501 |
583 |
$45,433.19 |
2.12% |
| GE HealthCare Technologies Inc. |
GEHC |
36266G107 |
562 |
$44,954.38 |
2.10% |
| Penumbra, Inc. |
PEN |
70975L107 |
153 |
$44,855.01 |
2.10% |
| Steris Plc |
STE |
G8473T100 |
169 |
$45,001.32 |
2.10% |
| Thermo Fisher Scientific Inc. |
TMO |
883556102 |
76 |
$44,903.08 |
2.10% |
| Agilent Technologies, Inc. |
A |
00846U101 |
292 |
$44,822.00 |
2.09% |
| Danaher Corporation |
DHR |
235851102 |
197 |
$44,675.66 |
2.09% |
| Sartorius Stedim Biotech |
DIM.FP |
F8005V210 |
184 |
$44,259.42 |
2.07% |
| Hologic, Inc. |
HOLX |
436440101 |
589 |
$44,157.33 |
2.06% |
| Hoya Corporation |
7741.JP |
J22848105 |
294 |
$44,137.31 |
2.06% |
| Medtronic Plc |
MDT |
G5960L103 |
418 |
$44,027.94 |
2.06% |
| Alcon Inc. |
ALC.SW |
H01301128 |
552 |
$43,893.31 |
2.05% |
| Merit Medical Systems, Inc. |
MMSI |
589889104 |
505 |
$43,727.95 |
2.04% |
| Olympus Corporation |
7733.JP |
J61240107 |
3,240 |
$43,559.21 |
2.04% |
| Bio-Rad Laboratories, Inc. (Class A) |
BIO |
090572207 |
134 |
$43,531.24 |
2.03% |
| Boston Scientific Corporation |
BSX |
101137107 |
418 |
$42,460.44 |
1.98% |
| Straumann Holding AG (Registered) |
STMN.SW |
H8300N127 |
369 |
$42,087.42 |
1.97% |
| West Pharmaceutical Services, Inc. |
WST |
955306105 |
152 |
$42,142.00 |
1.97% |
| Becton, Dickinson and Company |
BDX |
075887109 |
214 |
$41,520.28 |
1.94% |
| Carl Zeiss Meditec AG (Bearer) |
AFX.GY |
D14895102 |
805 |
$41,603.95 |
1.94% |
| Insulet Corporation |
PODD |
45784P101 |
127 |
$41,553.13 |
1.94% |
| Coloplast A/S (Class B) |
COLOB.DC |
K16018192 |
455 |
$41,058.72 |
1.92% |
| Fisher & Paykel Healthcare Corporation Limited |
FPH.NZ |
Q38992105 |
1,917 |
$41,039.85 |
1.92% |
| Zimmer Biomet Holdings, Inc. |
ZBH |
98956P102 |
421 |
$41,055.92 |
1.92% |
| Koninklijke Philips N.V. |
PHIA.NA |
N7637U112 |
1,452 |
$40,873.89 |
1.91% |
| Stryker Corporation |
SYK |
863667101 |
109 |
$40,458.62 |
1.89% |
| Cochlear Limited |
COH.AU |
Q25953102 |
215 |
$39,307.57 |
1.84% |
| Masimo Corporation |
MASI |
574795100 |
276 |
$39,310.68 |
1.84% |
| DexCom, Inc. |
DXCM |
252131107 |
612 |
$38,843.64 |
1.82% |
| Abbott Laboratories |
ABT |
002824100 |
301 |
$38,798.90 |
1.81% |
| Demant A/S |
DEMANT.DC |
K3008M105 |
1,129 |
$38,450.47 |
1.80% |
| Terumo Corporation |
4543.JP |
J83173104 |
2,460 |
$38,427.37 |
1.80% |
| Teleflex Incorporated |
TFX |
879369106 |
334 |
$38,216.28 |
1.79% |
| BioMerieux |
BIM.FP |
F1149Y232 |
300 |
$37,560.50 |
1.76% |
| ResMed Inc. |
RMD |
761152107 |
147 |
$37,607.01 |
1.76% |
| Smith & Nephew Plc |
SN/.LN |
G82343164 |
2,263 |
$37,578.87 |
1.76% |
| Sonova Holding AG (Registered) |
SOON.SW |
H8024W106 |
147 |
$36,626.44 |
1.71% |
| Siemens Healthineers AG |
SHL.GY |
D6T479107 |
729 |
$36,238.12 |
1.69% |
| WuXi AppTec Co., Ltd. (Class H) |
2359.HK |
Y971B1118 |
2,785 |
$36,200.07 |
1.69% |
| Amplifon SpA |
AMP.IM |
T0388E118 |
2,331 |
$35,811.19 |
1.67% |
| Baxter International Inc. |
BAX |
071813109 |
1,817 |
$34,050.58 |
1.59% |
| Sysmex Corporation |
6869.JP |
J7864H102 |
3,234 |
$30,766.23 |
1.44% |
| US Dollar |
$USD |
|
2,498 |
$2,498.43 |
0.12% |
| Japanese Yen |
$JPY |
|
58,181 |
$372.53 |
0.02% |
| Euro |
$EUR |
|
0 |
$0.06 |
0.00% |
| Pound Sterling |
$GBP |
|
0 |
$0.15 |
0.00% |
Holdings are subject to change.
The holdings information set forth above for the date indicated reflects creation and redemption transactions from the prior business day and may differ from the holdings information currently available from the Fund's custodian and accounting agent. With respect to the market value of the Fund's holdings set forth above, the pricing sources are generally third party vendors. The Fund ultimately relies on pricing information provided by the Fund's accounting agent.
|
|
The information presented is not intended to constitute an investment recommendation for, or advice to, any specific person. By providing this information, First Trust is not undertaking to give advice in any fiduciary capacity within the meaning of ERISA, the Internal Revenue Code or any other regulatory framework. Financial professionals are responsible for evaluating investment risks independently and for exercising independent judgment in determining whether investments are appropriate for their clients.
|